Clay Northam Wealth Management LLC Buys Shares of 3,853 Astera Labs, Inc. $ALAB

Clay Northam Wealth Management LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, Holdings Channel reports. The institutional investor bought 3,853 shares of the company’s stock, valued at approximately $1,861,000. Astera Labs accounts for 0.9% of Clay Northam Wealth Management LLC’s portfolio, making the stock its 20th biggest holding.

Other large investors also recently modified their holdings of the company. Reflection Asset Management acquired a new position in shares of Astera Labs in the 4th quarter valued at about $25,000. Smartleaf Asset Management LLC raised its stake in Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after acquiring an additional 152 shares during the period. Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new stake in Astera Labs during the fourth quarter worth about $33,000. Whipplewood Advisors LLC lifted its holdings in Astera Labs by 15,950.0% in the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after acquiring an additional 319 shares during the last quarter. Finally, Assetmark Inc. lifted its holdings in Astera Labs by 78.9% in the fourth quarter. Assetmark Inc. now owns 229 shares of the company’s stock worth $38,000 after acquiring an additional 101 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Insider Activity at Astera Labs

In other news, Director Manuel Alba sold 136,974 shares of the firm’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the transaction, the director directly owned 1,287,524 shares of the company’s stock, valued at approximately $569,098,483.24. This trade represents a 9.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief operating officer owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 419,244 shares of company stock worth $163,135,169 in the last ninety days. 10.40% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. Bank of America upped their target price on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. Zacks Research raised Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. Rothschild & Co Redburn began coverage on Astera Labs in a research report on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective for the company. Royal Bank Of Canada upped their price objective on Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Finally, Morgan Stanley increased their target price on Astera Labs to $335.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $333.00.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Scorpio growth is becoming the key catalyst: Analysts expect Scorpio to overtake Aries as Astera Labs’ largest product family, increasing the company’s semiconductor content per AI accelerator. Third-quarter revenue guidance implies approximately 40% sequential growth to about $550 million, while operating margins are expected to approach 43%. Astera Labs: Scorpio Is Becoming The Real Story
• Positive Sentiment: AI connectivity demand remains strong: Recent coverage points to record demand for Astera’s data-center connectivity products as hyperscalers and other customers expand AI infrastructure. The company’s latest quarter showed revenue growth of 104.5% year over year to $392.4 million, while EPS exceeded consensus estimates. Astera Labs stock in focus on record AI-connectivity demand
• Positive Sentiment: Analyst sentiment improved: Northland Securities upgraded ALAB to “Outperform.” MarketBeat reports a “Moderate Buy” consensus rating and an average price target of $333, while other analysts have raised targets following the company’s earnings report. Northland Securities Upgrades Astera Labs to Outperform
• Positive Sentiment: Strong relative growth profile: Comparisons with Credo and monday.com emphasize Astera’s accelerating quarterly revenue trajectory and exposure to AI connectivity, though investors should remember these are opinion-based comparisons rather than new company guidance. Credo vs. Astera Labs: Which AI Connectivity Stock Is the Better Buy?
• Neutral Sentiment: Insider sales were tax-related: CEO Jitendra Mohan, COO Sanjay Gajendra and General Counsel Philip Mazzara sold shares totaling roughly $64 million. The filings state the transactions covered tax withholding from vested equity awards, and each executive retained a substantial position; nevertheless, the sales could weigh on short-term sentiment. SEC insider transaction filing
• Negative Sentiment: Valuation and technical pressure remain risks: Astera trades at a price-to-earnings ratio above 140 and below its 50-day moving average. With a beta near 3.8, the stock is particularly sensitive to profit-taking and shifts in AI-sector sentiment after its sharp prior rally.

Astera Labs Trading Up 0.5%

ALAB opened at $290.52 on Friday. The business’s 50 day moving average is $354.34 and its 200-day moving average is $244.64. The stock has a market cap of $50.40 billion, a PE ratio of 143.82 and a beta of 3.84. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same period in the prior year, the company posted $0.44 EPS. The business’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.